Search
for
Sort by
Research 631–660 of 1000+
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- Vitiligo after Diphencyprone for Alopecia Areata
- Prophylaxis and Management of Skin Toxicities
- Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects
- Fatal Toxic Epidermal Necrolysis Associated with Minoxidil
- Side effects after artificial hair implants: 2 case reports
- Topical imiquimod—Be aware of the unexpected
- 572 Development of immunotherapies targeting TCR-Vβ2 for treatment of cutaneous T cell lymphoma
- Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management
- Nail involvement in frontal fibrosing alopecia
- Lucio Phenomenon: Sequelae of Neglected Leprosy
- Drug eruptions in dermatology
- Hair Loss in a Hemodialysis Patient after Repetitive Use of the Antipruritic Drug Nalfurafine: Implications of Impaired Angiogenesis for Hair Loss
- Treating Psoriasis: What Is New About Fumaric Acid Esters?
- Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
- Innovative Uses for Zinc in Dermatology
- CUTANEOUS SIDE-EFFECTS OF BETA-ADRENERGIC BLOCKERS
- Adverse cutaneous effects of psychotropic medications
- Smoker’s Mustache Revisited: Upper Lip Hair Yellow Discoloration Associated With Tobacco
- A Permanent Hair Loss in a Patient with Hypersensitivity to Intralesional Triamcinolone Injection
- The pharmacology of methotrexate
- Skin disorders in elderly subjects
- Cutaneous Markers of Disorders Affecting Adult Horses
- Cemotherapi Induce Alopecia Due Carboplatin-Paclitaxel Regiment
- CLINICAL STUDY OF CUTANEOUS MANIFESTATION OF GERIATRIC AGE GROUP
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- Semaglutide-Induced Atypical Pustular Drug Eruption: A Case Report
- Raynaud Phenomenon
- Tofacitinib therapy for children with severe alopecia areata